NEW

FDA Plans eMDR System Updates

The U.S. Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH) plans to update the FDA’s electronic medical device reporting (eMDR) system to reflect updates to the FDA Form 3500A and other system enhancements. The FDA Form 3500A is...

FDA Clears GE Healthcare’s Deep Learning-Based MR Image Reconstruction

GE Healthcare has announced U.S. FDA 510(k) clearance of AIR Recon DL. “This pioneering technology, using a deep learning-based neural network, improves the patient experience through shorter scan times while also increasing diagnostic confidence with better image...

GlobalData: Impact of COVID-19 on diagnostic imaging not as severe compared to other areas

The impact of COVID-19 on diagnostic imaging (DI) procedures will not be as severe compared to other therapy areas, such as aesthetics and dental, since only 38.7% of these procedures are elective and expected to drop due to the COVID-19 pandemic, according to...

FDA Approves Cerianna

PETNET Solutions Inc., a Siemens Healthineers company, and Zionexa USA, a wholly owned subsidiary of Zionexa SAS, have announced that the Food and Drug Administration (FDA) has approved Cerianna (fluoroestradiol F 18) injection for intravenous use. Cerianna...

How to Transition from OEM to Contracts to In House

This session will address how bringing OEM contracts in-house will result in cost-savings for your facility. By taking on more responsibility within your department and following a methodical approach to PMs, you can save your facility money and increase customer satisfaction. The speaker will provide examples, process, evaluation and completion of the move from OEM contracts to in-house management of imaging equipment.

David Francoeur, Senior Director, Brand Management, Sodexo Clinical Technology Management

Dave Francoeur has over 30 years of proven business, technical, leadership and operational management experience. He has worked at several companies within health care covering all aspects of the profession. His areas of experience in the HTM space include in-house, insurance, manufacturing and independent service organizations. His comprehensive knowledge in the HTM field is the contributing factor to his success in leadership roles. His passion is to infuse new ideas, challenge the status quo and take business system performance and productivity to the next level. His contributions to the profession include serving as president of five different local biomedical societies, chair of the United States Certification Committee, founding member and chair of the Technology Management Committee. He currently sits on the board of AAMI as well as many other industry-supporting activities.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *